Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Zomig (zolmitriptan) Nasal Spray, AstraZeneca NDA 21-450 9/30/03 10/10/03 10/10/03 | Zomig (zolmitriptan) tablets, AstraZeneca LP NDA 20-768/S-006 1/29/02 3/6/02 | Zomig (zolmitriptan) tablets & Zomig-ZMT (zolmitritpan) Orally Disintegrating Tablets, AstraZeneca LP NDA 20-768/S-010 & 21-231/S-03 10/9/02 10/21/02 | Zomig-ZMT (zolmitritpan) Orally Disintegrating Tablets, AstraZeneca NDA 21-231 2/13/01 3/30/01 3/30/01 | Zomig Indications: Acute treatment of Migraine. Zomig (zolmitriptan) nasal spray, AstraZeneca, Labeling Revision | Zomig (zolmitriptan) Tablets, AstraZeneca Pharma, Patient Population Altered | Zomig (zolmitriptan) Nasal Spray, AstraZeneca, Patient Population Altered | Zomig-ZMT (zolmitriptan) Orally Disintegrating Tablets, AstraZeneca Pharmaceuticals, Approval | Zomig (zolmitriptan) Tablets, AstraZeneca Pharmaceuticals, Labeling Revision | Zolmitriptan Tablets, Teva Pharmaceuticals, Tentative Approval | Zolmitriptan Tablets, Glenmark Generics Limited, Tentative Approval View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com